Clinical trials
Not yet recruiting Inflammatory Bowel Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Changhai Hospital | 1 |
| First Affiliated Hospital of Harbin Medical University | 1 |
| Ganzhou Hemay Pharmaceutical Co., Ltd | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| The Second Hospital of Nanjing Medical University | 1 |
| Wang Zhen | 1 |
| Xijing Hospital | 1 |
| iCell Gene Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 9 |
| Colitis, Ulcerative | 4 |
| Crohn Disease | 2 |
| Colitis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.